Average Insider

Where insiders trade, we follow

AFEYAN NOUBAR

Director
CIK: 1222012

All Transactions

DateCompanyTypeSharesPriceValueActions
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C987,491--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C12,723,940--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,777,752--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)P1,562,500$16.00$25,000,000.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)P1,562,500$16.00$25,000,000.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C18,483,785$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C17,016,215$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C1,500,000$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C843,881$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C1,265,822$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)P1,562,500$16.00$25,000,000.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C18,483,785$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C17,016,215$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C1,500,000$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C843,881$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C1,265,822$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,953,586$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,109,704$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,531,644$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C1,265,822$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,109,704$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)P1,562,500$16.00$25,000,000.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,953,586$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,109,704$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,531,644$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C1,265,822$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,109,704$0.00$0.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,777,752--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,777,752--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C12,723,940--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C987,491--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C13,702,224--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)P1,562,500$16.00$25,000,000.00View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C13,702,224--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)C2,777,752--View Details Filing
Mar 2, 2026Generate Biomedicines, Inc. (GENB)P1,562,500$16.00$25,000,000.00View Details Filing
Feb 26, 2026Generate Biomedicines, Inc. (GENB)A29,561$0.00$0.00View Details Filing
Feb 26, 2026Generate Biomedicines, Inc. (GENB)A29,561$0.00$0.00View Details Filing
Version: v26.3.23